Date	Period	Revenue/Estimate	Earnings Call
Aug 6, 2024	2025/Q1	239.760B / --	--
Feb 9, 2024	2024/Q3	171.645B / --	--
Aug 10, 2023	2024/Q1	151.650B / --	--
Feb 10, 2023	2023/Q3	161.679B / --	--
Aug 10, 2022	2023/Q1	136.378B / --	--

DatePeriodRevenue/EstimateEarnings Call

Aug 6, 20242025/Q1239.760B / ----

Feb 9, 20242024/Q3171.645B / ----

Aug 10, 20232024/Q1151.650B / ----

Feb 10, 20232023/Q3161.679B / ----

Aug 10, 20222023/Q1136.378B / ----

Unlock Free Earnings Estimates

Open Account

Yamae Group Holdings Earnings Reports

Yamae Group Holdings: Confirmation letter

Nov 6, 2024 01:32 ET

Yamae Group Holdings: Half-Year Report - Term 4 (2024/04/01 - 2025/03/31)

Nov 6, 2024 01:31 ET

Yamae Group Holdings: Presentation of financial results for the 2nd quarter of the fiscal year ending March 31, 2025

Nov 6, 2024 01:30 ET

Yamae Group Holdings: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

Nov 6, 2024 01:30 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.